Related Experiment Video
Updated: Jun 21, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Co-activator activator (CoAA) prevents the transcriptional activity of Runt domain transcription factors
Xiaodong Li1, Luke H Hoeppner, Eric D Jensen
1Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA.
Abstract:
Runx proteins are essential for a number of developmental processes and are aberrantly expressed in many human cancers. Runx factors bind DNA and co-factors to activate or repress genes crucial for bone formation, hematopoiesis, and neuronal development. Co-activator activator (CoAA) is a nuclear protein that regulates gene expression, RNA splicing and is overexpressed in many human tumors. In this study, we identified CoAA as a Runx2 binding protein. CoAA repressed Runx factor-dependent activation of reporter genes in a histone deacetylase-independent manner. CoAA also blocked Runx2-mediated repression of the Axin2 promoter, a novel Runx target gene. The carboxy-terminus of CoAA is essential for binding the Runt domains of Runx1 and Runx2. In electophoretic mobility shift assays, CoAA inhibited Runx2 interactions with DNA. These data indicate that CoAA is an inhibitor of Runx factors and can negate Runx factor regulation of gene expression. CoAA is expressed at high levels in human fetal osteoblasts and osteosarcoma cell lines. Suppression of CoAA expression by RNA interference reduced osteosarcoma cell viability in vitro, suggesting that it contributes to the proliferation and/or survival of osteoblast lineage cells.
Insights
Co-activator activator (CoAA) inhibits Runx factors, crucial proteins in development and cancer. Suppressing CoAA reduced osteosarcoma cell viability, suggesting its role in cell proliferation and survival.
Area of Science:
- Molecular Biology
- Developmental Biology
- Cancer Biology
Background:
- Runx proteins are essential transcription factors involved in development and aberrant in human cancers.
- Co-activator activator (CoAA) is a nuclear protein that regulates gene expression and is overexpressed in tumors.
Purpose of the Study:
- To investigate the interaction between CoAA and Runx factors.
- To determine the functional consequences of CoAA binding to Runx factors.
- To explore the role of CoAA in osteosarcoma.
Main Methods:
- Co-immunoprecipitation to identify CoAA as a Runx2 binding protein.
- Reporter gene assays to assess CoAA's effect on Runx-mediated gene activation and repression.
- Electrophoretic mobility shift assays (EMSA) to study Runx2-DNA interactions.
- RNA interference (RNAi) to suppress CoAA expression in osteosarcoma cells.
Main Results:
- CoAA directly binds to Runx1 and Runx2, with the carboxy-terminus of CoAA being essential for this interaction.
- CoAA represses Runx factor-dependent gene activation and blocks Runx2-mediated repression of the Axin2 promoter.
- CoAA inhibits Runx2 binding to DNA.
- CoAA is highly expressed in osteosarcoma cells, and its suppression reduces cell viability.
Conclusions:
- CoAA acts as an inhibitor of Runx factors, negatively regulating their transcriptional activity.
- CoAA plays a role in the proliferation and/or survival of osteoblast lineage cells, particularly in the context of osteosarcoma.
- CoAA represents a potential therapeutic target in osteosarcoma.
Related Concept Videos
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
Co-activators and Co-repressors
Co-activators and Co-repressors
RNA Polymerase II Accessory Proteins
RNA Polymerase II Accessory Proteins
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...

